1 month Elevance Health (NYSE:ELV) Price Target Cut to $551.00MarketBeat
Morgan Stanley reduced their price target on shares of Elevance Health from $643.00 to $551.00 and set an “overweight” rating for the company in a research report on Wednesday.
Health · Morgan Stanley (MS) · NYSE · Science
X